Replies to post #798503 on NorthWest Biotherapeutics Inc (NWBO)

[Smitty5150]

one more thing before I go. The 900m says absolutely nothing about where the UK MAA is in the process, so drop the "black box" BS. If NWBO is bumping up against the original, would it not make sense to increase for business dealings, etc vs. not having that kind flexibility? Of course it does. Just because they ask for it doesn't mean they will need it all. The old adage applies here:

"Its better to have it and not need it, than need it and not have it"

[Investor082]

LOL, Carry on with that Flaskworks/Eden BS!

Flaskworks/Eden commercial approval ain't happening until late 2027 but most likely 2028 at the earliest. No company will intentionally delay their approval when their survival depends on it. And MHRA does not care about volume at this stage given this is a novel personalized therapy.

So the harsh reality is that MHRA has told them what the problem is (likely needing patient level data) or they have told them that they cant approve until the new guidelines come in effect in spring/summer 2026. But certainly nothing to do with Flaskworks.

LP has been hiding the news from shareholders for a while, which is another indicator of how shady this management team is.

It’s also likely that the management will announce rejection a couple of months after the vote and subsequent new financing.